Clinical Trials in San Antonio

Showing 2701-2720 of 7,028 trials

A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors

NCT02829723

The purpose of this first-in-human (FIH) study of BLZ945 given as a single agent or in combination with PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of BLZ945, administered orally, as a single agent or in combination with PDR001, administered intravenously (i.v.) in adult patients with advanced solid tumors.

Advanced Solid Tumors

Novartis Pharmaceuticals192 participantsStarted Oct 2016

Boston, Massachusetts, United States • Nashville, Tennessee, United States • Houston, Texas, United States +11 more locations

COMPLETEDPhase 2/3< 1 mile

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

NCT04322708

This is a Phase 2/3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002) given monthly for 6 doses in adult and adolescent patients with active eosinophilic esophagitis. Subjects who complete the randomized, double-blind, placebo-controlled treatment may have the option to receive 6 doses of open-label lirentelimab (AK002) through the OLE Period of the study.

Eosinophilic Esophagitis

Allakos Inc.277 participantsStarted Jul 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Gilbert, Arizona, United States +75 more locations

A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

Find Trials by Condition in San Antonio

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

B0151005 Open-Label Extension Study

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Diffusion-Weighted MRI for Liver Metastasis

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

Study Evaluating Betrixaban in Pediatric Participants

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

A Study of OV101 in Individuals With Angelman Syndrome (AS)